A double-blind study to investigate the efficacy, safety and tolerability of Paroxetine in the treatment of depression in comparison with placebo
Depressive Disorder
Phase 2
The data from this study is provided in combined datasets containing data from other paroxetine studies. An annotated case report form and a reporting and analysis plan are not available for this study. A link to and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
May 2014